SCHEMBL9604010

SCHEMBL9604010

Cc1ccc(-c2ccc3oc4c(-c5ccc(-c6nc7ccccc7o6)cc5)cc(-c5ccc(C)cc5)cc4c3c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.54
RAB9A P51151 10/20 0.54
KDM4E B2RXH2 9/20 0.54
ALDH1A1 P00352 8/20 0.54
SMN1; SMN2 Q16637 7/20 0.54
HPGD P15428 7/20 0.54
HSD17B10 Q99714 4/20 0.54
TP53 P04637 3/20 0.54
CASP3 P42574 2/20 0.52
SENP8 Q96LD8 2/20 0.52
SENP7 Q9BQF6 2/20 0.52
SENP6 Q9GZR1 2/20 0.52
POLB P06746 1/20 0.52
MAPT P10636 4/20 0.47
USP2 O75604 2/20 0.47
HCRTR1 O43613 2/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
NFKB1 P19838 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9603992 0.92 NPC1 (0.49) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9604003 0.92 NPC1 (0.49) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9603999 0.90 NPC1 (0.47) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9604000 0.89 NPC1 (0.45) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9603980 0.88 NPC1 (0.58) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9604008 0.88 NPC1 (0.50) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9604012 0.88 NPC1 (0.48) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9604006 0.87 HPGD (0.46) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9603996 0.85 KDM4E (0.46) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9603993 0.84 NPC1 (0.52) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device XDH, AOX1, CYP4X1 NPC1 4611/4885RAB9A 3002/4885KDM4E 2142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.